Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Rasagiline 1 mg tablets in healthy Thai volunteers under fasting
TCTR20170519001Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Aug 2017
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of rasagiline (2 arms), sponsored by Bio-innova. Primary endpoint: Primary pharmacokinetic bioequivalence. Planned start Aug 2017; status: not yet recruiting.
02
Drugs
rasagiline
Beyond the preview
Go deeper on TCTR20170519001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20170519001.